Skip to main content

Edelman Joseph's Form 4 filing

Solid Biosciences Inc.SLDB · filed Feb 21, 2025

Accession no.
0001062993-25-003153
Filed
Feb 21, 2025, 4:17 PM ET
Trade date
Feb 19, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $20.1M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edelman JosephCIK 0001164426Director, 10% Owner
Perceptive Advisors LLCCIK 0001224962Director, 10% Owner
Perceptive Life Sciences Master Fund LtdCIK 0001249675Director, 10% Owner
Perceptive Xontogeny Venture Fund, LPCIK 0001757940Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 19, 2025Common StockPPurchaseAcquired+5,000,000$4.03+$20,150,00011,833,539Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)